| Meryll Ellen Pampolina Bouldin, MD | |
|
4301 West Markham, Slot 584, Little Rock, AR 72205-7199 | |
| (501) 526-2085 | |
| (501) 320-7068 |
| Full Name | Meryll Ellen Pampolina Bouldin |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 4301 West Markham, Slot 584, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184086613 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | E-11841 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uams Medical Center | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Arkansas | 4082528955 | 1121 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has closed its previously announced private placement.
The study involved 2.27 million people who were born in Denmark between 1950 and 1987, and were identified from national registers. Personal and family histories of epilepsy and psychosis were obtained, and individuals were monitored for up to 25 years.
A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body's attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology Research.
The Prostate Cancer Center of New Jersey, a partnership between AKSM/Oncology and the Urology Group of New Jersey (UGNJ), is the latest in a rapidly growing list of prostate-only treatment centers to earn the high honor of a three-year term of accreditation in radiation oncology.
› Verified 6 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has closed its previously announced private placement.
The study involved 2.27 million people who were born in Denmark between 1950 and 1987, and were identified from national registers. Personal and family histories of epilepsy and psychosis were obtained, and individuals were monitored for up to 25 years.
A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body's attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology Research.
The Prostate Cancer Center of New Jersey, a partnership between AKSM/Oncology and the Urology Group of New Jersey (UGNJ), is the latest in a rapidly growing list of prostate-only treatment centers to earn the high honor of a three-year term of accreditation in radiation oncology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meryll Ellen Pampolina Bouldin, MD 4301 W Markham St # 783, Little Rock, AR 72205-7101 Ph: (501) 686-8000 | Meryll Ellen Pampolina Bouldin, MD 4301 West Markham, Slot 584, Little Rock, AR 72205-7199 Ph: (501) 526-2085 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced it has closed its previously announced private placement.
The study involved 2.27 million people who were born in Denmark between 1950 and 1987, and were identified from national registers. Personal and family histories of epilepsy and psychosis were obtained, and individuals were monitored for up to 25 years.
A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body's attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology Research.
The Prostate Cancer Center of New Jersey, a partnership between AKSM/Oncology and the Urology Group of New Jersey (UGNJ), is the latest in a rapidly growing list of prostate-only treatment centers to earn the high honor of a three-year term of accreditation in radiation oncology.
› Verified 6 days ago
Dr. Armando Leonel Martinez, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St, Slot 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Sikandar Murad, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 802 N University Ave, Little Rock, AR 72205 Phone: 501-291-2322 Fax: 888-388-5166 | |
Dr. Joseph Baird Askew, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 S Shackleford Rd, Little Rock, AR 72211 Phone: 501-219-7000 | |
David Gregory Hinckley, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1701 S Shackleford Rd, Little Rock, AR 72211 Phone: 501-219-7000 | |
Matt Saenz, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4301 W Markham St # 584, Little Rock, AR 72205 Phone: 501-526-7485 | |
Dr. Timothy W Calicott, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 14623 Chambery Dr, Little Rock, AR 72211 Phone: 501-920-8556 | |
Christopher Wade Fowler, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St, Little Rock, AR 72205 Phone: 501-686-7000 |